Publications (52) LEYRE MONICA LOPEZ SORIA publications

filter_list

2024

  1. Chorioamnionitis of unusual etiology

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 42, Núm. 10, pp. 599-600

  2. Efficacy and safety of a structured de-escalation from antipseudomonal β-lactams in bloodstream infections due to Enterobacterales (SIMPLIFY): an open-label, multicentre, randomised trial

    The Lancet Infectious Diseases, Vol. 24, Núm. 4, pp. 375-385

  3. Epidemiological and clinical characterization of community, healthcare-associated and nosocomial colonization and infection due to carbapenemase-producing Klebsiella pneumoniae and Escherichia coli in Spain

    Infection, Vol. 52, Núm. 6, pp. 2231-2240

  4. Extensive tinea corporis caused by Trichophyton indotineae: Report of a case in Spain

    Journal of the European Academy of Dermatology and Venereology

  5. Infection by Saksenaea vasiformis in Spain: case report and literature review

    Enfermedades Infecciosas y Microbiologia Clinica

  6. Resistant fungal infection: a matter of importance not only in critical COVID patients

    Minerva Anestesiologica

2023

  1. Contemporary use of cefazolin for MSSA infective endocarditis: analysis of a national prospective cohort

    International Journal of Infectious Diseases, Vol. 137, pp. 134-143

  2. Gradient diffusion strips for detecting azole resistance in Aspergillus fumigatus sensu lato

    Mycoses, Vol. 66, Núm. 3, pp. 196-201

2022

  1. Detection of azole resistance in Aspergillus fumigatus complex isolates using MALDI-TOF mass spectrometry

    Clinical Microbiology and Infection, Vol. 28, Núm. 2, pp. 260-266

  2. In Vitro Antifungal Activity of Ibrexafungerp (SCY-078) Against Contemporary Blood Isolates From Medically Relevant Species of Candida: A European Study

    Frontiers in Cellular and Infection Microbiology, Vol. 12

  3. Outpatient Parenteral Antibiotic Treatment vs Hospitalization for Infective Endocarditis: Validation of the OPAT-GAMES Criteria

    Open Forum Infectious Diseases, Vol. 9, Núm. 9

  4. Screening of azole resistance in Aspergillus fumigatus using the EUCAST E.Def 10.2 azole-containing agar method: A single study suggests that filtration of conidial suspensions prior to inoculum preparation may not be needed

    Mycoses, Vol. 65, Núm. 11, pp. 1045-1049

  5. Study protocol for a randomized clinical trial to assess 7 versus 14-days of treatment for Pseudomonas aeruginosa bloodstream infections (SHORTEN-2 trial)

    PLoS ONE, Vol. 17, Núm. 12 December

2021

  1. Azole and amphotericin B MIC values against aspergillus fumigatus: High agreement between spectrophotometric and visual readings using the EUCAST EDef 9.3.2 procedure

    Antimicrobial Agents and Chemotherapy, Vol. 65, Núm. 1

  2. Azole resistance survey on clinical Aspergillus fumigatus isolates in Spain

    Clinical Microbiology and Infection, Vol. 27, Núm. 8, pp. 1170.e1-1170.e7

  3. Characterization and outcome of invasive infections due to Paecilomyces variotii: Analysis of patients from the FungiScope®registry and literature reports

    Journal of Antimicrobial Chemotherapy, Vol. 76, Núm. 3, pp. 765-774

  4. Clinical Features and Outcomes of Streptococcus anginosus Group Infective Endocarditis: A Multicenter Matched Cohort Study

    Open Forum Infectious Diseases, Vol. 8, Núm. 6

  5. Do high MICs predict the outcome in invasive fusariosis?

    The Journal of antimicrobial chemotherapy, Vol. 76, Núm. 4, pp. 1063-1069

  6. Invasive aspergillosis in solid organ transplantation: Diagnostic challenges and differences in outcome in a Spanish national cohort (Diaspersot study)

    Mycoses, Vol. 64, Núm. 11, pp. 1334-1345

  7. Mural Endocarditis: The GAMES Registry Series and Review of the Literature

    Infectious Diseases and Therapy, Vol. 10, Núm. 4, pp. 2749-2764